What makes promising pancreatic cancer drug different from chemotherapy?

The groundbreaking trial results reveal a new drug that extends the life of pancreatic cancer patients by doubling the survival rate compared to traditional chemotherapy. This significant advancement underscores the potential for innovative treatments to outperform established methods, offering hope to patients and families facing this devastating disease. The drug's success highlights the importance of continued research in cancer treatment and the need for new therapeutic approaches to improve patient outcomes.